Cargando…

Externally-Controlled Systems for Immunotherapy: From Bench to Bedside

Immunotherapy is a very promising therapeutic approach against cancer that is particularly effective when combined with gene therapy. Immuno-gene therapy approaches have led to the approval of four advanced therapy medicinal products (ATMPs) for the treatment of p53-deficient tumors (Gendicine and I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tristán-Manzano, María, Justicia-Lirio, Pedro, Maldonado-Pérez, Noelia, Cortijo-Gutiérrez, Marina, Benabdellah, Karim, Martin, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498544/ https://www.ncbi.nlm.nih.gov/pubmed/33013864 http://dx.doi.org/10.3389/fimmu.2020.02044

Ejemplares similares

Using Gene Editing Approaches to Fine-Tune the Immune System
por: Pavlovic, Kristina, et al.
Publicado: (2020)

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma
por: Maldonado-Pérez, Noelia, et al.
Publicado: (2022)

Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2023)

Natural Killer Cell Immunotherapy: From Bench to Bedside
por: Domogala, Anna, et al.
Publicado: (2015)

Physiological lentiviral vectors for the generation of improved CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2022)

Physiological lentiviral vectors for the generation of improved CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2022)

Targeting 4-1BB for tumor immunotherapy from bench to bedside
por: Wang, Ya-Tao, et al.
Publicado: (2022)

Improved Functionality of Integration-Deficient Lentiviral Vectors (IDLVs) by the Inclusion of IS(2) Protein Docks
por: Cortijo-Gutiérrez, Marina, et al.
Publicado: (2021)

Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers
por: Acebes-Fernández, Vanessa, et al.
Publicado: (2020)

CXCR2: From Bench to Bedside
por: Stadtmann, Anika, et al.
Publicado: (2012)

Genome‐edited adult stem cells: Next‐generation advanced therapy medicinal products
por: Benabdellah, Karim, et al.
Publicado: (2020)

Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside
por: Shamshiripour, Parisa, et al.
Publicado: (2022)

Bench, Bedside, Toolbox: T-Cells Deliver on Every Level
por: Laugel, Bruno
Publicado: (2014)

Investigating population-level immunosenescence: From bench to bedside
por: Cunha, Lucas Leite, et al.
Publicado: (2022)

From Bench to Bedside: Immunotherapy for Prostate Cancer
por: Tse, Brian Wan-Chi, et al.
Publicado: (2014)

Cancer photo-immunotherapy: from bench to bedside
por: Wang, Miao, et al.
Publicado: (2021)

Immunotherapy for Recurrent Glioma—From Bench to Bedside
por: Pu, Yi, et al.
Publicado: (2023)

Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
por: Alfaleh, Mohamed A., et al.
Publicado: (2020)

Non-coding RNAs in Rheumatoid Arthritis: From Bench to Bedside
por: Wang, Jinghua, et al.
Publicado: (2020)

From bench to bedside: the history and progress of CAR T cell therapy
por: Mitra, Aroshi, et al.
Publicado: (2023)

Development of Cellular Models to Study Efficiency and Safety of Gene Edition by Homologous Directed Recombination Using the CRISPR/Cas9 System
por: Sánchez-Hernández, Sabina, et al.
Publicado: (2020)

Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside
por: Ferreira, Valerie, et al.
Publicado: (2014)

Insights into the Role of Helicobacter pylori Infection in Preeclampsia: From the Bench to the Bedside
por: Tersigni, Chiara, et al.
Publicado: (2014)

Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside
por: Chae, Wook-Jin, et al.
Publicado: (2018)

Monomeric C-Reactive Protein and Cerebral Hemorrhage: From Bench to Bedside
por: Di Napoli, Mario, et al.
Publicado: (2018)

Combinatorial Herpes Simplex Vaccine Strategies: From Bedside to Bench and Back
por: Chentoufi, Aziz A., et al.
Publicado: (2022)

The paradoxical role of MDSCs in inflammatory bowel diseases: From bench to bedside
por: Zhao, Fan, et al.
Publicado: (2022)

Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Exosome: A New Player in Translational Nanomedicine
por: Aheget, Houssam, et al.
Publicado: (2020)

Bench and Bedside
por: Schmidt, Christian
Publicado: (2002)

The Hurdles From Bench to Bedside in the Realization and Implementation of a Universal Influenza Vaccine
por: Valkenburg, Sophie A., et al.
Publicado: (2018)

Targeting gamma delta T cells for cancer immunotherapy: bench to bedside
por: Gogoi, Dimpu, et al.
Publicado: (2013)

CAR-NK cells for cancer immunotherapy: from bench to bedside
por: Zhang, Leisheng, et al.
Publicado: (2022)

Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
por: Liu, Taoming, et al.
Publicado: (2020)

Circular RNAs Involve in Immunity of Digestive Cancers From Bench to Bedside: A Review
por: Chen, Chunyue, et al.
Publicado: (2022)

Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008)

From bench to bedside
por: Verdant, Colin L
Publicado: (2012)

The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
por: Goyvaerts, Cleo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8198ntkomr6tfe9lnt5uo9a7ss